Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial

NCT03322995 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: First-line Chemotherapy
DRUG: Second-line Chemotherapy
RADIATION: Chemoradiation

Sponsor

Medical College of Wisconsin